| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.13T | 2.87T | 2.81T | 2.66T | 2.51T | 2.29T |
| Gross Profit | 1.14T | 1.20T | 1.17T | 1.04T | 940.79B | 812.44B |
| EBITDA | 1.21T | 944.66B | 916.36B | 813.04B | 743.78B | 655.33B |
| Net Income | 469.53B | 351.63B | 346.13B | 290.34B | 317.38B | 192.38B |
Balance Sheet | ||||||
| Total Assets | 18.13T | 16.87T | 16.32T | 15.29T | 14.27T | 13.56T |
| Cash, Cash Equivalents and Short-Term Investments | 1.42T | 1.23T | 1.05T | 1.26T | 971.10B | 959.91B |
| Total Debt | 6.71T | 6.54T | 6.46T | 6.01T | 5.16T | 5.04T |
| Total Liabilities | 13.40T | 12.69T | 12.30T | 11.67T | 10.90T | 10.46T |
| Stockholders Equity | 4.58T | 4.09T | 3.94T | 3.54T | 3.26T | 3.03T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.20T | 1.17T | 777.66B | 990.65B | 1.04T |
| Operating Cash Flow | 0.00 | 1.27T | 1.25T | 881.23B | 1.03T | 1.08T |
| Investing Cash Flow | 0.00 | -1.31T | -1.36T | -1.14T | -784.99B | -1.18T |
| Financing Cash Flow | 0.00 | 146.27B | -100.99B | 480.70B | -330.47B | 20.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $32.15B | 10.73 | 10.88% | 2.72% | 7.10% | 12.75% | |
68 Neutral | $2.78B | 6.09 | 53.92% | 10.18% | -2.51% | 17.47% | |
68 Neutral | $6.56B | 10.25 | 23.40% | 6.07% | 9.51% | 29.38% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $8.75B | 21.69 | 15.23% | 0.99% | 3.86% | 28.06% | |
67 Neutral | $25.02B | 8.41 | 21.09% | 1.34% | -6.38% | 19.65% | |
51 Neutral | $12.84B | 16.52 | 5.74% | 2.58% | -6.89% | -33.20% |